We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
-2.6%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$7.35B
AUM Growth
-$159M
Cap. Flow
+$110M
Cap. Flow %
1.5%
Top 10 Hldgs %
34.24%
Holding
1,289
New
33
Increased
757
Reduced
419
Closed
47

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$7.26M
2
KVUE icon
Kenvue
KVUE
+$6.25M
3
BX icon
Blackstone
BX
+$6.2M
4
MSFT icon
Microsoft
MSFT
+$6.07M
5
MA icon
Mastercard
MA
+$5.73M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$4.58M
2
PH icon
Parker-Hannifin
PH
+$3.37M
3
MNST icon
Monster Beverage
MNST
+$2.91M
4
PAYX icon
Paychex
PAYX
+$2.36M
5
JNJ icon
Johnson & Johnson
JNJ
+$2.3M

Sector Composition

Rank Sector Weight
1 Technology 32.25%
2 Healthcare 12.54%
3 Consumer Discretionary 12.5%
4 Financials 10.64%
5 Communication Services 9.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EME icon
526
Emcor
EME
$32.6B
$1.55M 0.02%
7,365
-49
-0.7% -$10.3K
CHE icon
527
Chemed
CHE
$6.84B
$1.55M 0.02%
2,974
+54
+2% +$28.1K
REG icon
528
Regency Centers
REG
$13.8B
$1.54M 0.02%
25,980
+1,842
+8% +$116K
HRL icon
529
Hormel Foods
HRL
$11.9B
$1.54M 0.02%
40,468
+2,021
+5% +$79.6K
AAL icon
530
American Airlines Group
AAL
$9.03B
$1.54M 0.02%
120,076
+6,249
+5% +$97K
DAY
531
DELISTED
Dayforce
DAY
$1.53M 0.02%
22,588
+189
+0.8% +$13.3K
SRPT icon
532
Sarepta Therapeutics
SRPT
$2.2B
$1.53M 0.02%
12,610
+72
+0.6% +$8.14K
TREX icon
533
Trex
TREX
$4.66B
$1.51M 0.02%
24,503
-359
-1% -$24.6K
BJ icon
534
BJs Wholesale Club
BJ
$11.4B
$1.51M 0.02%
21,099
+29
+0.1% +$1.95K
GLPI icon
535
Gaming and Leisure Properties
GLPI
$12.4B
$1.5M 0.02%
33,025
+23,007
+230% +$1.1M
MUSA icon
536
Murphy USA
MUSA
$9.25B
$1.5M 0.02%
4,400
-20
-0.5% -$6.35K
EXEL icon
537
Exelixis
EXEL
$13.5B
$1.5M 0.02%
68,772
-964
-1% -$20.2K
RNR icon
538
RenaissanceRe
RNR
$13.7B
$1.5M 0.02%
7,590
+75
+1% +$14.4K
EQH icon
539
Equitable Holdings
EQH
$13.7B
$1.48M 0.02%
52,287
+1,207
+2% +$34.1K
PNR icon
540
Pentair
PNR
$9.84B
$1.48M 0.02%
22,911
+301
+1% +$20.3K
LAMR icon
541
Lamar Advertising Co
LAMR
$15.3B
$1.47M 0.02%
17,588
-101
-0.6% -$9.27K
TXRH icon
542
Texas Roadhouse
TXRH
$13.1B
$1.45M 0.02%
15,126
-160
-1% -$17K
NI icon
543
NiSource
NI
$19.5B
$1.45M 0.02%
58,881
+2,096
+4% +$56.6K
SCI icon
544
Service Corp International
SCI
$11.4B
$1.45M 0.02%
25,357
+1,389
+6% +$87.7K
CRL icon
545
Charles River Laboratories
CRL
$13.9B
$1.45M 0.02%
7,389
+335
+5% +$68.8K
LII icon
546
Lennox International
LII
$13.6B
$1.45M 0.02%
3,861
-76
-2% -$27.4K
MGM icon
547
MGM Resorts International
MGM
$10.6B
$1.44M 0.02%
39,263
-905
-2% -$40K
RGEN icon
548
Repligen
RGEN
$9.95B
$1.43M 0.02%
8,962
-70
-0.8% -$11.4K
KEY icon
549
KeyCorp
KEY
$23.4B
$1.42M 0.02%
132,383
+3,858
+3% +$42.7K
FERG icon
550
Ferguson
FERG
$44.2B
$1.42M 0.02%
8,640
+158
+2% +$24.9K

Similar funds

Xponance's Q3 2023 Portfolio in Review

As of Q3 2023, Xponance held 1,289 positions worth $7.35B, down 2.1% from $7.51B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Xponance's Q3 2023 filing shows 33 new, 757 increased, 419 reduced and 47 closed positions. Its largest new stake was Kenvue: 270,037 shares worth $5.42M. The largest sale was Cigna, an estimated $4.58M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Xponance's largest Q3 2023 buy was Kenvue: 270,037 shares worth $5.42M.
  • Xponance added most to Apple in Q3 2023, an estimated $7.26M increase.
  • Xponance's biggest Q3 2023 reduction was Cigna, cutting an estimated $4.58M.
  • Xponance fully exited Life Storage, Inc. in Q3 2023, selling an estimated $1.38M.
  • Xponance's ten largest holdings make up 34% of its $7.35B portfolio in Q3 2023.
  • Xponance opened 33 new positions and closed 47 in Q3 2023.
  • Xponance's portfolio value fell 2.1% quarter-over-quarter to $7.35B.

Based on Xponance's 13F filing for Q3 2023, filed 24 Oct 2023.